Mucormycosis in acute myeloid leukaemia.
Pandit
Sandeep R
SR
Division of Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, Milwaukee, WI, USA. spandit@mcw.edu
Raheem
Mohammed A
MA
D000208:Acute Disease; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000627:therapeutic use; D005629:Frozen Sections; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D035441:Thoracic Wall
D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D003561:Cytarabine; D000666:Amphotericin B; D015255:Idarubicin